Dosage and Administration of Metoclopramide for Nausea

Introduction to Metoclopramide Dosage

The American Gastroenterological Association recommends a standard dose of metoclopramide for nausea as 10 mg orally, 3 to 4 times a day, administered 30 minutes before meals and at bedtime 1
The therapeutic range for metoclopramide in treating refractory gastroparesis is 5 to 20 mg, 3 to 4 times a day 1

The American College of Gastroenterology suggests starting with 10 mg of metoclopramide orally, 3 times a day before meals, for at least 4 weeks to evaluate efficacy in gastroparesis 2
For severe nausea, initiating treatment with intravenous or intramuscular metoclopramide and then switching to oral administration once symptoms are controlled is recommended, although the specific details are not cited here.

If metoclopramide alone fails, adding (not replacing) agents with different mechanisms of action, such as ondansetron (4-8 mg every 8 hours) or prochlorperazine (5-10 mg, 3-4 times a day), may be considered 3

The FDA maintains a boxed warning for the risk of tardive dyskinesia with metoclopramide use, indicating a need for cautious prescribing practices 2

The standard oral dosage of metoclopramide is 10-30 mg 3-4 times daily before meals, as recommended by the American Society of Clinical Oncology 4

Monitor for sedation, which typically precedes respiratory depression, as advised by the American Society of Clinical Oncology 5
For patients reporting previous episodes of nausea during past exposure to opioids, prevention may include pretreatment with metoclopramide around the clock for the first few days, according to the American Society of Clinical Oncology 5
Tolerance to nausea typically develops within a few days of starting treatment, as noted by the American Society of Clinical Oncology 5
Metoclopramide has both central and peripheral effects and is recommended as first-line for the management of chronic nausea, as suggested by the American Society of Clinical Oncology 5
Rule out other causes of nausea (constipation, other medications) before attributing symptoms solely to the primary condition, as recommended by the American Society of Clinical Oncology 5